Conference-abstractCancer Immunol Res2026
The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma.
- Journal
- Cancer Immunol Res
- Published
- 1 November 2026
- Citations
- 0
- Type
- Conference-abstract
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 6
- HuR’s role in pancreatic cancer metastasis F30CA306284↗
- Community Outreach and Engagement P30CA069533↗
- Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer R01CA212600↗
- Developing a patient derived model platform to treat BRCA1/2-mutant pancreatic cancers R21CA263996↗
- Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens U01CA224012↗
- Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified commun… U01CA278923↗